Enhanced expression of cytochrome P450 in stomach cancer

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1040-1044

  Murray, G I ^a   Taylor, M C ^a   Burke, M D ^a,b   Melvin, W T ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Cytochrome P450; Neoplasm; Stomach

Indexed keywords

CYTOCHROME P450;

ARTICLE; DRUG DEVELOPMENT; ENVIRONMENTAL FACTOR; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0031906566     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.173     Document Type: Article

References (32)

1. Capdevila JH, Falck JR and Estabrook RW (1992) Cytochrome P450 and the arachidonate cascade. FASEB J 6: 731-736
2. Correa P (1988) A human model of gastric carcinogenesis. Cancer Res 48: 3554-3560
3. Filipe MI (1990) Gastrointestinal carcinoma and its precursor lesions. In Histocheinistry in Pathology, Filipe MI and Lake BD. (eds), pp. 175-180. Churchill Livingstone; Edinburgh
4. Foster JR, Idle JR, Hardwick JP, Bars R, Scott P and Braganza JM (1993) Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 169: 457-463
5. Gonzalez FJ and Gelboin UV (1994) Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26: 165-183
6. Huang Q, Stoner G, Resau J, Nickols J and Mirvish SS (1992) Metabolism of N-nitrosomethyl-n-amylamine by microsomes from human and rat esophagus. Cancer Res 52: 3547-2551
7. Kaminsky LS and Fasco MJ (1992) Small intestinal cytochromes P450. Crit Rev Toxicol 21:407-422
8. Kitada M and Kamataki T (1994) Cytochrome P450 in human fetal liver: significance and fetal specific expression. Drug Melab Dispos 26: 305-323
9. Kivistö KT, Kroemer UK and Eichelbaum M (1995a) The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol 40: 523-530
10. Kivistö KT, Fritz P, Liinder A, Friedel G, Beaune P and Kroemer HK (1995b) Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem Cell Biol 103: 25-29
11. Koop DR (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6: 724-730
12. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and the so-called intestinal type carcinoma. Acta Pathol Microbiol Scand A 64: 31-49
13. Massaad L, de Eaziers I, Ribrag V, Janot F, Beaune P, Morizte J, Gouyette A and Chabot GG (1992) Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res 52: 6567-6575
14. McKay JA. Murray GI, Weaver RJ, Ewen SWB, Melvin WT and Burke MD (1993) Xenobiotic metabolising enzyme expression in colonie neoplasia. Gut 34: 1234-1239
15. McKinnon RA, Burgess WM, Hall PM, Abdul-Aziz Z and McManus ME (1992) Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503 A proteins in the presence of flavonoids. Cancer Res 52: 2108s-2113s
16. McKinnon RA, Burgess WM, Hall PM, Roberts-Thomson SJ, Gonzalez FJ and McManus ME (1995) Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 36: 259-267
17. Murray GI and Burke MD (1995) Immunohisiochemisiry of drug metabolizing enzymes. Biochem Pharmacol 50: 895-903
18. Murray GI, Barnes TS, Sewell HF, Ewen SWB, Melvin WT and Burke MD (1988) The immunocytochemical localisalion and distribution of cylochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 25: 465-475
19. Murray GI, Weaver RJ, Paterson PJ, Ewen SWB, Melvin WT and Burke MD (1993) Expression of xenobiotic metabolising enzymes in breast cancer. J Pathol 169: 347-353
20. Murray GI, Shaw D, Weaver RJ, McKay JA, Ewen SWB, Melvin WT and Burke MD (1994) Cytochrome P450 expression in oesophageal cancer. Gut 35: 599-603
21. Nakajima T, Wang RS, Nimura Y, Pin YM, He M, Vainio H, Murayama N, Aoyama T and Iida F (1996) Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis 17: 1477-1481
22. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon JM, Estabrook RW, Gunsalus IC and Neben DW (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42
23. Paterson LH (1993) Rationale for the use of N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive drugs. Cancer Metast Rev 12: 119-234
24. Roberts-Thomson SJ, McManus ME, Tukey RH, Gonzalez FJ and Holder GM (1995) Metabolism of polycyclic aza-aromatic carcinogens catalyzes by four expressed human cytochromes P450. Cancer Res 55: 1052-1059
25. Schuetz JD, Beach DL and Guzelian PS (1994) Selective expression of cytochrome P450 mRNAs in embryonic and adult human liver. Pharmacogenetics 4: 11-20
26. Schwartzman ML, Martasek P, Rios AR, Levere RD, Solangi K, Goodman AI and Abraham NG (1990) Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int 37: 94-99
27. Schweikl H, Taylor JW, Kitareewan S, Linko P, Nagorney D and Goldestein JA (1993) Expression of CYP1A1 and CYP1A2 in human liver. Pharmacogenetics 3: 239-249
28. Shimada T and Guengerich FP (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4: 391-407
29. Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH and Guengerich, FP (1992) Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41: 856-864
30. Stemmermann GN (1994) Intestinal metaplasia of the stomach. Cancer 74: 556-564
31. Thompson GB, van Heerden JA and Sarr MG (1993) Adenocarcinoma of the stomach: are we making progress? Lancet 342: 713-718
32. Weaver RJ, Thompson S, Smith G, Dickins M, Elcombe CR, Mayor RT and Burke MD (1994) A comparative study of constitutive and induced alkoxyresorufin o-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaco fasciularis), human, mouse, rat and hamster liver microsomes. Biochem Pharmacol 47: 763-773